About OncoLens
OncoLens is a company based in Atlanta (United States) founded in 2015 by Anju Mathew.. OncoLens has raised $27.1 million across 4 funding rounds from investors including Atlanta Technology Angels, BIP Ventures and Cross-Border Impact Ventures. The company has 35 employees as of December 31, 2023. OncoLens offers products and services including OncoLens Platform, Molecular Store, Integrate Module, and Collaborate Module. OncoLens operates in a competitive market with competitors including Medshr, F6S Network, Omnidoc, Liangyihui and Curofy, among others.
- Headquarter Atlanta, United States
- Employees 35 as on 31 Dec, 2023
- Founders Anju Mathew
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lynkcare, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$27.1 M (USD)
in 4 rounds
-
Latest Funding Round
$16 M (USD), Series B
Oct 02, 2024
-
Investors
Atlanta Technology Angels
& 4 more
-
Employee Count
35
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OncoLens
OncoLens offers a comprehensive portfolio of products and services, including OncoLens Platform, Molecular Store, Integrate Module, and Collaborate Module. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Integrates data for precise cancer treatment and collaboration
Stores biomarkers for research and treatment recommendations
Connects EMR systems for real-time patient information
Enables real-time team discussions on cancer cases
Unlock access to complete
Unlock access to complete
Funding Insights of OncoLens
OncoLens has successfully raised a total of $27.1M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $16 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $16.0M
-
First Round
First Round
(26 Mar 2019)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Series B - OncoLens | Valuation | BIP Ventures , Cross Border Impact Ventures | |
| Jan, 2021 | Amount | Series A - OncoLens | Valuation | Martin Ventures , BIP Ventures |
|
| Jan, 2020 | Amount | Seed - OncoLens | Valuation | BIP Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OncoLens
OncoLens has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Atlanta Technology Angels, BIP Ventures and Cross-Border Impact Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are provided by BIP Ventures.
|
Founded Year | Domain | Location | |
|
Investments are focused on health technology for global impact.
|
Founded Year | Domain | Location | |
|
Early-stage tech focused VC firm investing in geographies such as the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OncoLens
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OncoLens
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oncolens Comparisons
Competitors of OncoLens
OncoLens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medshr, F6S Network, Omnidoc, Liangyihui and Curofy, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Knowledge sharing platform for Physicians
|
|
| domain | founded_year | HQ Location |
Provider of platforms for startups to find investors, talent and other resources
|
|
| domain | founded_year | HQ Location |
Provider of social discussion platform for physicians
|
|
| domain | founded_year | HQ Location |
Medical information platform for cancer
|
|
| domain | founded_year | HQ Location |
Online network for doctors' communication and patient referrals is provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oncolens
Frequently Asked Questions about OncoLens
When was OncoLens founded?
OncoLens was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Where is OncoLens located?
OncoLens is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Who is the current CEO of OncoLens?
Anju Mathew is the current CEO of OncoLens. They have also founded this company.
Is OncoLens a funded company?
OncoLens is a funded company, having raised a total of $27.1M across 4 funding rounds to date. The company's 1st funding round was a Seed of $2.5M, raised on Mar 26, 2019.
How many employees does OncoLens have?
As of Dec 31, 2023, the latest employee count at OncoLens is 35.
What does OncoLens do?
OncoLens is a HIPAA compliant mobile and web-based platform for connecting oncologists. The platform enables physicians to create a tumor board and also allows them and other care providers to discuss and develop treatment plans for their cancer patients in real-time. OncoLens also enables the discussion of cases among colleagues and care teams without the involvement of a tumor board. Through the engagement of clinical trial researchers, cases can be identified early on as potential candidates for clinical trials.
Who are the top competitors of OncoLens?
OncoLens's top competitors include F6S Network, Curofy and Medshr.
What products or services does OncoLens offer?
OncoLens offers OncoLens Platform, Molecular Store, Integrate Module, and Collaborate Module.
Who are OncoLens's investors?
OncoLens has 5 investors. Key investors include Atlanta Technology Angels, BIP Ventures, Cross-Border Impact Ventures, Martin Ventures, and seedToB.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.